Overview

The Pharmacists Expand Access to Reproductive heaLthcare (PEARL) study investigates whether women who are administered hormonal contraception by a pharmacist have different results than women who are administered by a clinician in terms of unintended pregnancies and contraceptive continuation. Pharmacists are now allowed to administer hormonal contraceptives like the patch and the pill and this study aims to look at the results to see if it improves contraceptive continuation and prevents unintended pregnancies.

Study Information

The study will follow women who initiate or continue hormonal birth control from certain pharmacies for a year. The women will be surveyed to collect the information that the researchers need.

Inclusion Criteria

• Women ages 18-51
• Present to initiate hormonal contraception at a study pharmacy

Exclusion Criteria

• Pregnant women
• Contraindications to hormonal contraception
• Under 18
• Unable or unwilling to consent

Locations

Oregon Health & Science University

Portland, Oregon, United States, 97239

Contact: Women’s Health Research Unit Confidential Recruitment Line    503-494-3666 whru@ohsu.edu 

Principal Investigator: Maria I Rodriguez, MD, MPH Oregon Health and Science University

Sponsors/Collaborators

Oregon Health and Science University

Laura and John Arnold Foundation